|
Levine, S Z; Kodesh, A; Goldberg, Y et al. (2016) Initial severity and efficacy of risperidone in autism: Results from the RUPP trial. Eur Psychiatry 32:16-20
|
|
Aman, Michael; Rettiganti, Mallikarjuna; Nagaraja, Haikady N et al. (2015) Tolerability, Safety, and Benefits of Risperidone in Children and Adolescents with Autism: 21-Month Follow-up After 8-Week Placebo-Controlled Trial. J Child Adolesc Psychopharmacol 25:482-93
|
|
McCracken, J T; Badashova, K K; Posey, D J et al. (2014) Positive effects of methylphenidate on hyperactivity are moderated by monoaminergic gene variants in children with autism spectrum disorders. Pharmacogenomics J 14:295-302
|
|
Tobiasova, Zuzana; van der Lingen, Klaas H B; Scahill, Lawrence et al. (2011) Risperidone-related improvement of irritability in children with autism is not associated with changes in serum of epidermal growth factor and interleukin-13. J Child Adolesc Psychopharmacol 21:555-64
|
|
Jahromi, Laudan B; Kasari, Connie L; McCracken, James T et al. (2009) Positive effects of methylphenidate on social communication and self-regulation in children with pervasive developmental disorders and hyperactivity. J Autism Dev Disord 39:395-404
|
|
Nikolov, Roumen N; Bearss, Karen E; Lettinga, Jelle et al. (2009) Gastrointestinal symptoms in a sample of children with pervasive developmental disorders. J Autism Dev Disord 39:405-13
|
|
Sukhodolsky, Denis G; Scahill, Lawrence; Gadow, Kenneth D et al. (2008) Parent-rated anxiety symptoms in children with pervasive developmental disorders: frequency and association with core autism symptoms and cognitive functioning. J Abnorm Child Psychol 36:117-28
|
|
Anderson, George M; Scahill, Lawrence; McCracken, James T et al. (2007) Effects of short- and long-term risperidone treatment on prolactin levels in children with autism. Biol Psychiatry 61:545-50
|
|
Posey, David J; Aman, Michael G; McCracken, James T et al. (2007) Positive effects of methylphenidate on inattention and hyperactivity in pervasive developmental disorders: an analysis of secondary measures. Biol Psychiatry 61:538-44
|
|
Research Units on Pediatric Psychopharmacology Autism Network (2005) Randomized, controlled, crossover trial of methylphenidate in pervasive developmental disorders with hyperactivity. Arch Gen Psychiatry 62:1266-74
|
Showing the most recent 10 out of 14 publications
